James W. Jr. Newman
CIK 1718364 · last filed 2025-06-02
James W. Jr. Newman is a corporate insider who has filed 12 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ADIL, was dated Jun 2, 2025. Across all open-market trades the lifetime net is +$122.6K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
12
$122.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADIL | Director | — | $2.98 | — | $0 | 2 | 2025-06-02 |
| ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Director | 54,475 | $0.00 | $49 | $122.6K | 10 | 2023-05-25 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-02 | ADIL | Grant (A) | — | $0 | EDGAR |
| 2024-03-27 | ADIL | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-25 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-03 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Buy (P) | +25,000 | $67.3K | EDGAR |
| 2021-11-30 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Buy (P) | +10,000 | $28.5K | EDGAR |
| 2021-02-10 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-28 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | +3,731 | $0 | EDGAR |
| 2020-03-30 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Buy (P) | +19,644 | $26.8K | EDGAR |
| 2020-03-05 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |